Global Non-Opioid Pain Treatment Market Research Report 2023

Report ID: 2006056 | Published Date: Sep 2024 | No. of Page: 91 | Base Year: 2023 | Rating: 3.9 | Webstory: Check our Web story
Request Sample Report
Pre-Order Enquiry
Request Discount(%) 
1 Report Overview
    1.1 Study Scope
    1.2 Market Analysis by Type
        1.2.1 Global Non-Opioid Pain Treatment Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
        1.2.2 Medical Cannabis Treatment
        1.2.3 Capsaicin-derived Treatment
        1.2.4 Menthol-containing Treatment
        1.2.5 Omega 3 fatty acid-containing Treatment
        1.2.6 Botulinum Toxins
    1.3 Market by Application
        1.3.1 Global Non-Opioid Pain Treatment Market Growth by Application: 2018 VS 2022 VS 2029
        1.3.2 Orthopaedic and Musculoskeletal Pain
        1.3.3 Neuropathic Pain
        1.3.4 Cancer Pain
        1.3.5 Others
    1.4 Study Objectives
    1.5 Years Considered
    1.6 Years Considered
2 Global Growth Trends
    2.1 Global Non-Opioid Pain Treatment Market Perspective (2018-2029)
    2.2 Non-Opioid Pain Treatment Growth Trends by Region
        2.2.1 Global Non-Opioid Pain Treatment Market Size by Region: 2018 VS 2022 VS 2029
        2.2.2 Non-Opioid Pain Treatment Historic Market Size by Region (2018-2023)
        2.2.3 Non-Opioid Pain Treatment Forecasted Market Size by Region (2024-2029)
    2.3 Non-Opioid Pain Treatment Market Dynamics
        2.3.1 Non-Opioid Pain Treatment Industry Trends
        2.3.2 Non-Opioid Pain Treatment Market Drivers
        2.3.3 Non-Opioid Pain Treatment Market Challenges
        2.3.4 Non-Opioid Pain Treatment Market Restraints
3 Competition Landscape by Key Players
    3.1 Global Top Non-Opioid Pain Treatment Players by Revenue
        3.1.1 Global Top Non-Opioid Pain Treatment Players by Revenue (2018-2023)
        3.1.2 Global Non-Opioid Pain Treatment Revenue Market Share by Players (2018-2023)
    3.2 Global Non-Opioid Pain Treatment Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
    3.3 Players Covered: Ranking by Non-Opioid Pain Treatment Revenue
    3.4 Global Non-Opioid Pain Treatment Market Concentration Ratio
        3.4.1 Global Non-Opioid Pain Treatment Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Top 10 and Top 5 Companies by Non-Opioid Pain Treatment Revenue in 2022
    3.5 Non-Opioid Pain Treatment Key Players Head office and Area Served
    3.6 Key Players Non-Opioid Pain Treatment Product Solution and Service
    3.7 Date of Enter into Non-Opioid Pain Treatment Market
    3.8 Mergers & Acquisitions, Expansion Plans
4 Non-Opioid Pain Treatment Breakdown Data by Type
    4.1 Global Non-Opioid Pain Treatment Historic Market Size by Type (2018-2023)
    4.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2024-2029)
5 Non-Opioid Pain Treatment Breakdown Data by Application
    5.1 Global Non-Opioid Pain Treatment Historic Market Size by Application (2018-2023)
    5.2 Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2024-2029)
6 North America
    6.1 North America Non-Opioid Pain Treatment Market Size (2018-2029)
    6.2 North America Non-Opioid Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    6.3 North America Non-Opioid Pain Treatment Market Size by Country (2018-2023)
    6.4 North America Non-Opioid Pain Treatment Market Size by Country (2024-2029)
    6.5 United States
    6.6 Canada
7 Europe
    7.1 Europe Non-Opioid Pain Treatment Market Size (2018-2029)
    7.2 Europe Non-Opioid Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    7.3 Europe Non-Opioid Pain Treatment Market Size by Country (2018-2023)
    7.4 Europe Non-Opioid Pain Treatment Market Size by Country (2024-2029)
    7.5 Germany
    7.6 France
    7.7 U.K.
    7.8 Italy
    7.9 Russia
    7.10 Nordic Countries
8 Asia-Pacific
    8.1 Asia-Pacific Non-Opioid Pain Treatment Market Size (2018-2029)
    8.2 Asia-Pacific Non-Opioid Pain Treatment Market Growth Rate by Region: 2018 VS 2022 VS 2029
    8.3 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2018-2023)
    8.4 Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2024-2029)
    8.5 China
    8.6 Japan
    8.7 South Korea
    8.8 Southeast Asia
    8.9 India
    8.10 Australia
9 Latin America
    9.1 Latin America Non-Opioid Pain Treatment Market Size (2018-2029)
    9.2 Latin America Non-Opioid Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    9.3 Latin America Non-Opioid Pain Treatment Market Size by Country (2018-2023)
    9.4 Latin America Non-Opioid Pain Treatment Market Size by Country (2024-2029)
    9.5 Mexico
    9.6 Brazil
10 Middle East & Africa
    10.1 Middle East & Africa Non-Opioid Pain Treatment Market Size (2018-2029)
    10.2 Middle East & Africa Non-Opioid Pain Treatment Market Growth Rate by Country: 2018 VS 2022 VS 2029
    10.3 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2018-2023)
    10.4 Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2024-2029)
    10.5 Turkey
    10.6 Saudi Arabia
    10.7 UAE
11 Key Players Profiles
    11.1 Allergan PLC
        11.1.1 Allergan PLC Company Detail
        11.1.2 Allergan PLC Business Overview
        11.1.3 Allergan PLC Non-Opioid Pain Treatment Introduction
        11.1.4 Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.1.5 Allergan PLC Recent Development
    11.2 Canopy Growth
        11.2.1 Canopy Growth Company Detail
        11.2.2 Canopy Growth Business Overview
        11.2.3 Canopy Growth Non-Opioid Pain Treatment Introduction
        11.2.4 Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.2.5 Canopy Growth Recent Development
    11.3 Medical Marijuana Inc.
        11.3.1 Medical Marijuana Inc. Company Detail
        11.3.2 Medical Marijuana Inc. Business Overview
        11.3.3 Medical Marijuana Inc. Non-Opioid Pain Treatment Introduction
        11.3.4 Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.3.5 Medical Marijuana Inc. Recent Development
    11.4 Panag Pharma Inc.
        11.4.1 Panag Pharma Inc. Company Detail
        11.4.2 Panag Pharma Inc. Business Overview
        11.4.3 Panag Pharma Inc. Non-Opioid Pain Treatment Introduction
        11.4.4 Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.4.5 Panag Pharma Inc. Recent Development
    11.5 Tilray
        11.5.1 Tilray Company Detail
        11.5.2 Tilray Business Overview
        11.5.3 Tilray Non-Opioid Pain Treatment Introduction
        11.5.4 Tilray Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.5.5 Tilray Recent Development
    11.6 Aphria Inc.
        11.6.1 Aphria Inc. Company Detail
        11.6.2 Aphria Inc. Business Overview
        11.6.3 Aphria Inc. Non-Opioid Pain Treatment Introduction
        11.6.4 Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.6.5 Aphria Inc. Recent Development
    11.7 Bedrocan
        11.7.1 Bedrocan Company Detail
        11.7.2 Bedrocan Business Overview
        11.7.3 Bedrocan Non-Opioid Pain Treatment Introduction
        11.7.4 Bedrocan Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.7.5 Bedrocan Recent Development
    11.8 Cara Therapeutics
        11.8.1 Cara Therapeutics Company Detail
        11.8.2 Cara Therapeutics Business Overview
        11.8.3 Cara Therapeutics Non-Opioid Pain Treatment Introduction
        11.8.4 Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.8.5 Cara Therapeutics Recent Development
    11.9 Centrexion Therapeutics
        11.9.1 Centrexion Therapeutics Company Detail
        11.9.2 Centrexion Therapeutics Business Overview
        11.9.3 Centrexion Therapeutics Non-Opioid Pain Treatment Introduction
        11.9.4 Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.9.5 Centrexion Therapeutics Recent Development
    11.10 CHT Medical
        11.10.1 CHT Medical Company Detail
        11.10.2 CHT Medical Business Overview
        11.10.3 CHT Medical Non-Opioid Pain Treatment Introduction
        11.10.4 CHT Medical Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.10.5 CHT Medical Recent Development
    11.11 Cronos Group
        11.11.1 Cronos Group Company Detail
        11.11.2 Cronos Group Business Overview
        11.11.3 Cronos Group Non-Opioid Pain Treatment Introduction
        11.11.4 Cronos Group Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.11.5 Cronos Group Recent Development
    11.12 GW Pharmaceuticals
        11.12.1 GW Pharmaceuticals Company Detail
        11.12.2 GW Pharmaceuticals Business Overview
        11.12.3 GW Pharmaceuticals Non-Opioid Pain Treatment Introduction
        11.12.4 GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.12.5 GW Pharmaceuticals Recent Development
    11.13 Medropharm Gmbh
        11.13.1 Medropharm Gmbh Company Detail
        11.13.2 Medropharm Gmbh Business Overview
        11.13.3 Medropharm Gmbh Non-Opioid Pain Treatment Introduction
        11.13.4 Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.13.5 Medropharm Gmbh Recent Development
    11.14 US Worldmeds LLC
        11.14.1 US Worldmeds LLC Company Detail
        11.14.2 US Worldmeds LLC Business Overview
        11.14.3 US Worldmeds LLC Non-Opioid Pain Treatment Introduction
        11.14.4 US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2018-2023)
        11.14.5 US Worldmeds LLC Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
    13.1 Research Methodology
        13.1.1 Methodology/Research Approach
        13.1.2 Data Source
    13.2 Disclaimer
    13.3 Author Details

List of Tables
    Table 1. Global Non-Opioid Pain Treatment Market Size Growth Rate by Type (US$ Million): 2018 VS 2022 VS 2029
    Table 2. Key Players of Medical Cannabis Treatment
    Table 3. Key Players of Capsaicin-derived Treatment
    Table 4. Key Players of Menthol-containing Treatment
    Table 5. Key Players of Omega 3 fatty acid-containing Treatment
    Table 6. Key Players of Botulinum Toxins
    Table 7. Global Non-Opioid Pain Treatment Market Size Growth by Application (US$ Million): 2018 VS 2022 VS 2029
    Table 8. Global Non-Opioid Pain Treatment Market Size by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 9. Global Non-Opioid Pain Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 10. Global Non-Opioid Pain Treatment Market Share by Region (2018-2023)
    Table 11. Global Non-Opioid Pain Treatment Forecasted Market Size by Region (2024-2029) & (US$ Million)
    Table 12. Global Non-Opioid Pain Treatment Market Share by Region (2024-2029)
    Table 13. Non-Opioid Pain Treatment Market Trends
    Table 14. Non-Opioid Pain Treatment Market Drivers
    Table 15. Non-Opioid Pain Treatment Market Challenges
    Table 16. Non-Opioid Pain Treatment Market Restraints
    Table 17. Global Non-Opioid Pain Treatment Revenue by Players (2018-2023) & (US$ Million)
    Table 18. Global Non-Opioid Pain Treatment Market Share by Players (2018-2023)
    Table 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2022)
    Table 20. Ranking of Global Top Non-Opioid Pain Treatment Companies by Revenue (US$ Million) in 2022
    Table 21. Global 5 Largest Players Market Share by Non-Opioid Pain Treatment Revenue (CR5 and HHI) & (2018-2023)
    Table 22. Key Players Headquarters and Area Served
    Table 23. Key Players Non-Opioid Pain Treatment Product Solution and Service
    Table 24. Date of Enter into Non-Opioid Pain Treatment Market
    Table 25. Mergers & Acquisitions, Expansion Plans
    Table 26. Global Non-Opioid Pain Treatment Market Size by Type (2018-2023) & (US$ Million)
    Table 27. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2018-2023)
    Table 28. Global Non-Opioid Pain Treatment Forecasted Market Size by Type (2024-2029) & (US$ Million)
    Table 29. Global Non-Opioid Pain Treatment Revenue Market Share by Type (2024-2029)
    Table 30. Global Non-Opioid Pain Treatment Market Size by Application (2018-2023) & (US$ Million)
    Table 31. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2018-2023)
    Table 32. Global Non-Opioid Pain Treatment Forecasted Market Size by Application (2024-2029) & (US$ Million)
    Table 33. Global Non-Opioid Pain Treatment Revenue Market Share by Application (2024-2029)
    Table 34. North America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 35. North America Non-Opioid Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 36. North America Non-Opioid Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 37. Europe Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 38. Europe Non-Opioid Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 39. Europe Non-Opioid Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 40. Asia-Pacific Non-Opioid Pain Treatment Market Size Growth Rate by Region (US$ Million): 2018 VS 2022 VS 2029
    Table 41. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2018-2023) & (US$ Million)
    Table 42. Asia-Pacific Non-Opioid Pain Treatment Market Size by Region (2024-2029) & (US$ Million)
    Table 43. Latin America Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 44. Latin America Non-Opioid Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 45. Latin America Non-Opioid Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 46. Middle East & Africa Non-Opioid Pain Treatment Market Size Growth Rate by Country (US$ Million): 2018 VS 2022 VS 2029
    Table 47. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2018-2023) & (US$ Million)
    Table 48. Middle East & Africa Non-Opioid Pain Treatment Market Size by Country (2024-2029) & (US$ Million)
    Table 49. Allergan PLC Company Detail
    Table 50. Allergan PLC Business Overview
    Table 51. Allergan PLC Non-Opioid Pain Treatment Product
    Table 52. Allergan PLC Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 53. Allergan PLC Recent Development
    Table 54. Canopy Growth Company Detail
    Table 55. Canopy Growth Business Overview
    Table 56. Canopy Growth Non-Opioid Pain Treatment Product
    Table 57. Canopy Growth Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 58. Canopy Growth Recent Development
    Table 59. Medical Marijuana Inc. Company Detail
    Table 60. Medical Marijuana Inc. Business Overview
    Table 61. Medical Marijuana Inc. Non-Opioid Pain Treatment Product
    Table 62. Medical Marijuana Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 63. Medical Marijuana Inc. Recent Development
    Table 64. Panag Pharma Inc. Company Detail
    Table 65. Panag Pharma Inc. Business Overview
    Table 66. Panag Pharma Inc. Non-Opioid Pain Treatment Product
    Table 67. Panag Pharma Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 68. Panag Pharma Inc. Recent Development
    Table 69. Tilray Company Detail
    Table 70. Tilray Business Overview
    Table 71. Tilray Non-Opioid Pain Treatment Product
    Table 72. Tilray Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 73. Tilray Recent Development
    Table 74. Aphria Inc. Company Detail
    Table 75. Aphria Inc. Business Overview
    Table 76. Aphria Inc. Non-Opioid Pain Treatment Product
    Table 77. Aphria Inc. Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 78. Aphria Inc. Recent Development
    Table 79. Bedrocan Company Detail
    Table 80. Bedrocan Business Overview
    Table 81. Bedrocan Non-Opioid Pain Treatment Product
    Table 82. Bedrocan Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 83. Bedrocan Recent Development
    Table 84. Cara Therapeutics Company Detail
    Table 85. Cara Therapeutics Business Overview
    Table 86. Cara Therapeutics Non-Opioid Pain Treatment Product
    Table 87. Cara Therapeutics Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 88. Cara Therapeutics Recent Development
    Table 89. Centrexion Therapeutics Company Detail
    Table 90. Centrexion Therapeutics Business Overview
    Table 91. Centrexion Therapeutics Non-Opioid Pain Treatment Product
    Table 92. Centrexion Therapeutics Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 93. Centrexion Therapeutics Recent Development
    Table 94. CHT Medical Company Detail
    Table 95. CHT Medical Business Overview
    Table 96. CHT Medical Non-Opioid Pain Treatment Product
    Table 97. CHT Medical Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 98. CHT Medical Recent Development
    Table 99. Cronos Group Company Detail
    Table 100. Cronos Group Business Overview
    Table 101. Cronos Group Non-Opioid Pain Treatment Product
    Table 102. Cronos Group Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 103. Cronos Group Recent Development
    Table 104. GW Pharmaceuticals Company Detail
    Table 105. GW Pharmaceuticals Business Overview
    Table 106. GW Pharmaceuticals Non-Opioid Pain Treatment Product
    Table 107. GW Pharmaceuticals Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 108. GW Pharmaceuticals Recent Development
    Table 109. Medropharm Gmbh Company Detail
    Table 110. Medropharm Gmbh Business Overview
    Table 111. Medropharm Gmbh Non-Opioid Pain Treatment Product
    Table 112. Medropharm Gmbh Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 113. Medropharm Gmbh Recent Development
    Table 114. US Worldmeds LLC Company Detail
    Table 115. US Worldmeds LLC Business Overview
    Table 116. US Worldmeds LLC Non-Opioid Pain Treatment Product
    Table 117. US Worldmeds LLC Revenue in Non-Opioid Pain Treatment Business (2018-2023) & (US$ Million)
    Table 118. US Worldmeds LLC Recent Development
    Table 119. Research Programs/Design for This Report
    Table 120. Key Data Information from Secondary Sources
    Table 121. Key Data Information from Primary Sources
List of Figures
    Figure 1. Global Non-Opioid Pain Treatment Market Size Comparison by Type (2023-2029) & (US$ Million)
    Figure 2. Global Non-Opioid Pain Treatment Market Share by Type: 2022 VS 2029
    Figure 3. Medical Cannabis Treatment Features
    Figure 4. Capsaicin-derived Treatment Features
    Figure 5. Menthol-containing Treatment Features
    Figure 6. Omega 3 fatty acid-containing Treatment Features
    Figure 7. Botulinum Toxins Features
    Figure 8. Global Non-Opioid Pain Treatment Market Size Comparison by Application (2023-2029) & (US$ Million)
    Figure 9. Global Non-Opioid Pain Treatment Market Share by Application: 2022 VS 2029
    Figure 10. Orthopaedic and Musculoskeletal Pain Case Studies
    Figure 11. Neuropathic Pain Case Studies
    Figure 12. Cancer Pain Case Studies
    Figure 13. Others Case Studies
    Figure 14. Non-Opioid Pain Treatment Report Years Considered
    Figure 15. Global Non-Opioid Pain Treatment Market Size (US$ Million), Year-over-Year: 2018-2029
    Figure 16. Global Non-Opioid Pain Treatment Market Size, (US$ Million), 2018 VS 2022 VS 2029
    Figure 17. Global Non-Opioid Pain Treatment Market Share by Region: 2022 VS 2029
    Figure 18. Global Non-Opioid Pain Treatment Market Share by Players in 2022
    Figure 19. Global Top Non-Opioid Pain Treatment Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Non-Opioid Pain Treatment as of 2022)
    Figure 20. The Top 10 and 5 Players Market Share by Non-Opioid Pain Treatment Revenue in 2022
    Figure 21. North America Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 22. North America Non-Opioid Pain Treatment Market Share by Country (2018-2029)
    Figure 23. United States Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 24. Canada Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 25. Europe Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 26. Europe Non-Opioid Pain Treatment Market Share by Country (2018-2029)
    Figure 27. Germany Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 28. France Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 29. U.K. Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 30. Italy Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 31. Russia Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 32. Nordic Countries Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 33. Asia-Pacific Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 34. Asia-Pacific Non-Opioid Pain Treatment Market Share by Region (2018-2029)
    Figure 35. China Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 36. Japan Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 37. South Korea Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 38. Southeast Asia Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 39. India Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 40. Australia Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 41. Latin America Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 42. Latin America Non-Opioid Pain Treatment Market Share by Country (2018-2029)
    Figure 43. Mexico Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 44. Brazil Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 45. Middle East & Africa Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 46. Middle East & Africa Non-Opioid Pain Treatment Market Share by Country (2018-2029)
    Figure 47. Turkey Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 48. Saudi Arabia Non-Opioid Pain Treatment Market Size YoY Growth (2018-2029) & (US$ Million)
    Figure 49. Allergan PLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 50. Canopy Growth Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 51. Medical Marijuana Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 52. Panag Pharma Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 53. Tilray Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 54. Aphria Inc. Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 55. Bedrocan Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 56. Cara Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 57. Centrexion Therapeutics Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 58. CHT Medical Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 59. Cronos Group Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 60. GW Pharmaceuticals Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 61. Medropharm Gmbh Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 62. US Worldmeds LLC Revenue Growth Rate in Non-Opioid Pain Treatment Business (2018-2023)
    Figure 63. Bottom-up and Top-down Approaches for This Report
    Figure 64. Data Triangulation
    Figure 65. Key Executives Interviewed
Please ask for List of Figures. Request Sample Report
Companies Included in Reports:
Allergan PLC
Canopy Growth
Medical Marijuana Inc.
Panag Pharma Inc.
Tilray
Aphria Inc.
Bedrocan
Cara Therapeutics
Centrexion Therapeutics
CHT Medical
Cronos Group
GW Pharmaceuticals
Medropharm Gmbh
US Worldmeds LLC
Frequently Asked Questions
Non-Opioid Pain Treatment report offers great insights of the market and consumer data and their interpretation through various figures and graphs. Report has embedded global market and regional market deep analysis through various research methodologies. The report also offers great competitor analysis of the industries and highlights the key aspect of their business like success stories, market development and growth rate.
Non-Opioid Pain Treatment report is categorised based on following features:
  1. Global Market Players
  2. Geopolitical regions
  3. Consumer Insights
  4. Technological advancement
  5. Historic and Future Analysis of the Market
Non-Opioid Pain Treatment report is designed on the six basic aspects of analysing the market, which covers the SWOT and SWAR analysis like strength, weakness, opportunity, threat, aspirations and results. This methodology helps investors to reach on to the desired and correct decision to put their capital into the market.

Related Reports